FILTER
FILTERED INTERVIEW RESULTS
Girish Chovatia
CHAIRMAN AND MANAGING DIRECTOR, AMI LIFE SCIENCES
Ami Life Sciences is research driven generic API manufacturer as well as working on custom synthesis of New Chemical Entities.
Rahul Maheshwari
MANAGING DIRECTOR, DEFI HEALTHCARE
DEFI Healthcare is an Ahmedabad-based pharmaceutical company involved in the manufacturing and supply of a wide range of avant-garde pharmaceuticals to semi-regulated and non-regulated markets across the globe.
Dr. Seyfullah Dağıstanlı & Aytek Dağıstanlı
FOUNDER & BUSINESS DEVELOPMENT MANAGER, DELTAPV
DeltaPV is Turkey’s leading provider of pharmacovigilance in Turkey and exports its services abroad.
Peter Meath
MANAGING DIRECTOR & CO-HEAD OF HEALTHCARE AND LIFE SCIENCES, J.P. MORGAN COMMERCIAL BANKING
.P.Morgan explains the complete ecosystem that it has developed for life science companies, aiming to serve their needs throughout their entire life cycle, from opening a bank account on Day 1, to expanding internationally and through a potential IPO and beyond.
Ferhat Farsi
CEO AND CO-FOUNDER, CINNAGEN
CinnaGen Co. was founded in 1994 with the goal of manufacturing hi-tech products in biotechnology and related fields.
Fatih Yedikardeş
GENERAL MANAGER, DAIICHI SANKYO
Daiichi is a global pharmaceutical company that is developing Turkey as a regional hub.
Bharat Desai
MANAGING DIRECTOR, BHARAT PARENTERALS LIMITED
Bharat Parenterals is a research driven pharmaceutical company with a dedicated facility for antiretroviral drugs as well as a facility for general and B-lactam group of drugs.
John Patrick Oroho
EXECUTIVE VICE PRESIDENT AND CHIEF STRATEGY OFFICER, PORZIO LIFE SCIENCES, LLC
Porzio Life Sciences, LLC (PorzioLS) is a provider of compliance operations products and services for the life sciences industry, and a wholly‐owned subsidiary of the Porzio, Bromberg & Newman, P.C. law firm.
Zafer Toksoz
CHAIRMAN, ARVEN PHARMACEUTICALS
Arven Pharmaceuticals is an R&D based high-tech pharmaceutical company with a focus on research and development, manufacturing and marketing of high-tech pharmaceutical products, including biotech drugs and multi-dose innovative devices for dry powder inhalers.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Africa Energy 2025
GBR is pleased to release its Africa Energy 2025 report, following four months of interviews and research across Sub-Saharan Africa, during which time we met with over 120 companies, including those in the upstream, midstream, and downstream sectors, as well as governments, financiers, and service providers.
GBR is pleased to release its Africa Energy 2025 report, following four months of interviews and research across Sub-Saharan Africa, during which time we met with over 120 companies, including those in the upstream, midstream, and downstream sectors, as well as governments, financiers, and service providers.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
